347 related articles for article (PubMed ID: 33096151)
1. ANAVIP® interaction with western pygmy rattlesnake venom: In vitro assesment of reactivity using SE-HPLC.
Tanner DA; Shults CA; Sanny C
Toxicon; 2020 Dec; 188():159-163. PubMed ID: 33096151
[TBL] [Abstract][Full Text] [Related]
2. Comparison of F(ab')
Mascarenas DN; Fullerton L; Smolinske SC; Warrick BJ; Seifert SA
Toxicon; 2020 Oct; 186():42-45. PubMed ID: 32763251
[TBL] [Abstract][Full Text] [Related]
3. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
[TBL] [Abstract][Full Text] [Related]
4. Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021.
Brandehoff N; Dalton A; Daugherty C; Dart RC; Monte AA;
J Med Toxicol; 2023 Jul; 19(3):248-254. PubMed ID: 37115482
[TBL] [Abstract][Full Text] [Related]
5. Use of both Fab and F(ab')
Martin AM; Wang GS; Poel K
Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188
[TBL] [Abstract][Full Text] [Related]
6. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
[TBL] [Abstract][Full Text] [Related]
7. Use of Crotalidae equine immune F(ab')
Wilson BZ; Larsen J; Smelski G; Dudley S; Shirazi FM
Clin Toxicol (Phila); 2021 Nov; 59(11):1023-1026. PubMed ID: 33703984
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms.
Anderson SG; Gutiérrez JM; Ownby CL
Toxicon; 1993 Aug; 31(8):1051-9. PubMed ID: 8212043
[TBL] [Abstract][Full Text] [Related]
9. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
Dudley S; Smelski G; Massey DJ; Maciulewicz T; Cardwell MD; Shirazi FM
Toxicon; 2022 Jun; 212():49-54. PubMed ID: 35413335
[TBL] [Abstract][Full Text] [Related]
10. Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America.
Calvete JJ; Sanz L; Cid P; de la Torre P; Flores-Díaz M; Dos Santos MC; Borges A; Bremo A; Angulo Y; Lomonte B; Alape-Girón A; Gutiérrez JM
J Proteome Res; 2010 Jan; 9(1):528-44. PubMed ID: 19863078
[TBL] [Abstract][Full Text] [Related]
11. Polyvalent Snake Antivenoms: Production Strategy and Their Therapeutic Benefits.
Ratanabanangkoon K
Toxins (Basel); 2023 Aug; 15(9):. PubMed ID: 37755943
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family Crotalidae.
Ownby CL; Colberg TR
Toxicon; 1990; 28(2):189-99. PubMed ID: 2339435
[TBL] [Abstract][Full Text] [Related]
13. Comparative venomics of the Prairie Rattlesnake (Crotalus viridis viridis) from Colorado: Identification of a novel pattern of ontogenetic changes in venom composition and assessment of the immunoreactivity of the commercial antivenom CroFab®.
Saviola AJ; Pla D; Sanz L; Castoe TA; Calvete JJ; Mackessy SP
J Proteomics; 2015 May; 121():28-43. PubMed ID: 25819372
[TBL] [Abstract][Full Text] [Related]
14. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management.
Boldrini-França J; Corrêa-Netto C; Silva MM; Rodrigues RS; De La Torre P; Pérez A; Soares AM; Zingali RB; Nogueira RA; Rodrigues VM; Sanz L; Calvete JJ
J Proteomics; 2010 Aug; 73(9):1758-76. PubMed ID: 20542151
[TBL] [Abstract][Full Text] [Related]
15. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
[TBL] [Abstract][Full Text] [Related]
16. Crotaline Fab antivenom reverses platelet dysfunction induced by Crotalus scutulatus venom: an in vitro study.
Carstairs SD; Kreshak AA; Tanen DA
Acad Emerg Med; 2013 May; 20(5):522-5. PubMed ID: 23672368
[TBL] [Abstract][Full Text] [Related]
17. Intraspecific variability of the Central American rattlesnake (Crotalus simus) venom and its usefulness to obtain a representative standard venom.
Gómez A; Solano G; Chang-Castillo A; Chacón D; Corrales G; Segura Á; Estrada R; León G
Toxicon; 2021 Oct; 202():20-26. PubMed ID: 34562491
[TBL] [Abstract][Full Text] [Related]
18. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom.
Richardson WH; Goto CS; Gutglass DJ; Williams SR; Clark RF
Clin Toxicol (Phila); 2007; 45(5):472-5. PubMed ID: 17503249
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four different immunogens for the production of snake antivenoms.
Li Q; Ownby CL
Toxicon; 1992 Nov; 30(11):1319-30. PubMed ID: 1485332
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbant assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom.
Schaeffer RC; Randall H; Resk J; Carlson RW
Toxicon; 1988; 26(1):67-76. PubMed ID: 3347932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
